202 related articles for article (PubMed ID: 28007549)
1. Estimation of age-specific rates of reactivation and immune boosting of the varicella zoster virus.
Marinelli I; van Lier A; de Melker H; Pugliese A; van Boven M
Epidemics; 2017 Jun; 19():1-12. PubMed ID: 28007549
[TBL] [Abstract][Full Text] [Related]
2. The impact of childhood varicella vaccination on the incidence of herpes zoster in the general population: modelling the effect of exogenous and endogenous varicella-zoster virus immunity boosting.
Sauboin C; Holl K; Bonanni P; Gershon AA; Benninghoff B; Carryn S; Burgess MA; Wutzler P
BMC Infect Dis; 2019 Feb; 19(1):126. PubMed ID: 30727971
[TBL] [Abstract][Full Text] [Related]
3. Distribution of Health Effects and Cost-effectiveness of Varicella Vaccination are Shaped by the Impact on Herpes Zoster.
van Lier A; Lugnér A; Opstelten W; Jochemsen P; Wallinga J; Schellevis F; Sanders E; de Melker H; van Boven M
EBioMedicine; 2015 Oct; 2(10):1494-9. PubMed ID: 26629544
[TBL] [Abstract][Full Text] [Related]
4. Point-Counterpoint: The Hope-Simpson Hypothesis and Its Implications Regarding an Effect of Routine Varicella Vaccination on Herpes Zoster Incidence.
Harpaz R; van Hoek AJ
J Infect Dis; 2018 Sep; 218(suppl_2):S57-S62. PubMed ID: 30247602
[TBL] [Abstract][Full Text] [Related]
5. Projections of zoster incidence in Australia based on demographic and transmission models of varicella-zoster virus infection.
Costantino V; Gidding HF; Wood JG
Vaccine; 2017 Dec; 35(48 Pt B):6737-6742. PubMed ID: 29050801
[TBL] [Abstract][Full Text] [Related]
6. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix.
Ouwens MJ; Littlewood KJ; Sauboin C; Téhard B; Denis F; Boëlle PY; Alain S
Clin Ther; 2015 Apr; 37(4):816-829.e10. PubMed ID: 25726457
[TBL] [Abstract][Full Text] [Related]
7. The natural history of varicella zoster virus infection in Norway: Further insights on exogenous boosting and progressive immunity to herpes zoster.
Marangi L; Mirinaviciute G; Flem E; Scalia Tomba G; Guzzetta G; Freiesleben de Blasio B; Manfredi P
PLoS One; 2017; 12(5):e0176845. PubMed ID: 28545047
[TBL] [Abstract][Full Text] [Related]
8. Modeling the impact of combined vaccination programs against varicella and herpes zoster in Norway.
Marchetti S; Guzzetta G; Flem E; Mirinaviciute G; Scalia Tomba G; Manfredi P
Vaccine; 2018 Feb; 36(8):1116-1125. PubMed ID: 29366704
[TBL] [Abstract][Full Text] [Related]
9. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries.
Poletti P; Melegaro A; Ajelli M; Del Fava E; Guzzetta G; Faustini L; Scalia Tomba G; Lopalco P; Rizzo C; Merler S; Manfredi P
PLoS One; 2013; 8(4):e60732. PubMed ID: 23613740
[TBL] [Abstract][Full Text] [Related]
10. Modelling varicella vaccination - What does a lack of surge in herpes zoster incidence tell us about exogenous boosting?
Widgren K; Tomba GS; Leung KY; Giesecke J
Vaccine; 2022 Jan; 40(4):673-681. PubMed ID: 34930603
[TBL] [Abstract][Full Text] [Related]
11. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus transmission dynamics in Vojvodina, Serbia.
Medić S; Katsilieris M; Lozanov-Crvenković Z; Siettos CI; Petrović V; Milošević V; Brkić S; Andrews N; Ubavić M; Anastassopoulou C
PLoS One; 2018; 13(3):e0193838. PubMed ID: 29505590
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination.
de Melker H; Berbers G; Hahné S; Rümke H; van den Hof S; de Wit A; Boot H
Vaccine; 2006 May; 24(18):3946-52. PubMed ID: 16564115
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on optimal control of varicella and herpes zoster by mass routine varicella vaccination.
Betta M; Laurino M; Pugliese A; Guzzetta G; Landi A; Manfredi P
Proc Biol Sci; 2016 Mar; 283(1826):20160054. PubMed ID: 26984627
[TBL] [Abstract][Full Text] [Related]
15. Cost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiology.
Goldman GS
Vaccine; 2005 May; 23(25):3349-55. PubMed ID: 15837242
[TBL] [Abstract][Full Text] [Related]
16. Hope-Simpson's progressive immunity hypothesis as a possible explanation for herpes zoster incidence data.
Guzzetta G; Poletti P; Del Fava E; Ajelli M; Scalia Tomba GP; Merler S; Manfredi P
Am J Epidemiol; 2013 May; 177(10):1134-42. PubMed ID: 23548754
[TBL] [Abstract][Full Text] [Related]
17. Understanding the role of exogenous boosting in modeling varicella vaccination.
Talbird SE; La EM; Mauskopf J; Altland A; Daniels V; Wolfson LJ
Expert Rev Vaccines; 2018 Nov; 17(11):1021-1035. PubMed ID: 30354696
[TBL] [Abstract][Full Text] [Related]
18. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program.
Tanuseputro P; Zagorski B; Chan KJ; Kwong JC
Vaccine; 2011 Nov; 29(47):8580-4. PubMed ID: 21939721
[TBL] [Abstract][Full Text] [Related]
19. High varicella zoster virus susceptibility in Caribbean island populations: Implications for vaccination.
Vos RA; Mollema L; van Boven M; van Lier A; Smits G; Janga-Jansen AVA; Baboe-Kalpoe S; Hulshof K; Stienstra Y; van der Klis FRM; de Melker HE
Int J Infect Dis; 2020 May; 94():16-24. PubMed ID: 32112964
[TBL] [Abstract][Full Text] [Related]
20. Live Attenuated Zoster Vaccine Boosts Varicella Zoster Virus (VZV)-Specific Humoral Responses Systemically and at the Cervicovaginal Mucosa of Kenyan VZV-Seropositive Women.
Perciani CT; Sekhon M; Hundal S; Farah B; Ostrowski MA; Anzala AO; McKinnon LR; Jaoko W; MacDonald KS;
J Infect Dis; 2018 Sep; 218(8):1210-1218. PubMed ID: 29800309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
